Author | Thierry André, MD


Thierry André, MD, on Interim Results from the Phase III Keynote-177 Study

June 01, 2020

The findings, presented at the 2020 ASCO Virtual Scientific Program, are the first to show benefit with pembrolizumab in patients with advanced colorectal cancer when used as a front-line therapy.